ImmuCell
ICCC
28 hedge funds and large institutions have $7.2M invested in ImmuCell in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
67% more capital invested
Capital invested by funds: $4.31M → $7.2M (+$2.89M)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
12% more funds holding
Funds holding: 25 → 28 (+3)
0.32% more ownership
Funds ownership: 10.04% → 10.36% (+0.32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$387K |
| 2 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$191K |
| 3 |
Renaissance Technologies
New York
|
+$182K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$142K |
| 5 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$26.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRC
Shufro Rose & Co
New York
|
-$307K |
| 2 |
HPC
HM Payson & Co
Portland,
Maine
|
-$174K |
| 3 |
RC
RBF Capital
San Francisco,
California
|
-$78K |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
-$60K |
| 5 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$24.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
26
Harbour Investments
Madison,
Wisconsin
| $2K | +$2.35K | +250 | New |
|
27
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
RC
28
RBF Capital
San Francisco,
California
| – | -$78K | -13,086 | Closed |
|
|
ISL
29
Ingalls & Snyder LLC
New York
| – | -$60K | -10,000 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | +$19 | +2 | +6% |
|
ICCC Hedge Fund Activity: Q1 2021 in Review
28 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2021, worth a combined $7.2M — up 67% from $4.31M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ICCC positions and 2 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $387K. The largest seller was Shufro Rose & Co, cutting an estimated $307K.
- 28 institutional investors held ImmuCell (ICCC) as of Q1 2021, up from 25 in Q4 2020.
- Funds reported $7.2M of ImmuCell stock for Q1 2021, up 67% quarter-over-quarter.
- 5 funds opened new ImmuCell positions in Q1 2021 and 2 closed out, a net change of +3 holders.
- The largest ImmuCell buyer in Q1 2021 was Vanguard Group, an estimated $387K added.
- The largest ImmuCell seller in Q1 2021 was Shufro Rose & Co, an estimated $307K sold.
Based on aggregated 13F filings for Q1 2021.